logo
U.S. may expand Nvidia and AMD's 15% China chips deal to other companies

U.S. may expand Nvidia and AMD's 15% China chips deal to other companies

Yahoo19 hours ago
Investing.com -- The White House indicated on Tuesday that the recent agreement with Nvidia (NASDAQ:NVDA) and Advanced Micro Devices (NASDAQ:AMD) to share revenue from certain China chip sales could potentially extend to other semiconductor companies.
Under the current arrangement, Nvidia and AMD have agreed to give the U.S. government 15% of revenue generated from sales of specific advanced chips to China.
White House Press Secretary Karoline Leavitt addressed the agreement during a press briefing, calling it "a creative idea and solution" that "stands with these two companies, perhaps it could expand in the future to other companies."
Related articles
U.S. may expand Nvidia and AMD's 15% China chips deal to other companies
Tesla: Hype Aside, How Much Is the EV Giant Really Worth Now?
If Powell goes, does Fed trust go with him?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Analog Devices (ADI) Sees Bullish Sentiment Backed by Sector Tailwinds
Analog Devices (ADI) Sees Bullish Sentiment Backed by Sector Tailwinds

Yahoo

time24 minutes ago

  • Yahoo

Analog Devices (ADI) Sees Bullish Sentiment Backed by Sector Tailwinds

Analog Devices Inc. (NASDAQ:ADI) is one of the best large-cap tech stocks to buy now. In mid-July, Tore Svanberg, an analyst at Stifel Nicolaus, raised his price target on Analog Devices to $270 from $248 while reiterating a Buy rating. In his view, the prolonged inventory correction across the semiconductor sector over the past two years has likely reached its trough, setting the stage for a cyclical rebound. However, it is difficult to gauge how quickly the rebound will unfold. Within this report, Svanberg also communicated his broader sector outlook, which continues to favour AI-linked semiconductor names. He expects the AI-focused companies under his coverage to post median revenue growth of 32% in 2025 and 17% in 2026, thus underscoring the structural demand tailwinds in this space. Within that context, Analog Devices is seen as well-positioned to benefit from the upturn, supporting the case for maintaining an overweight stance in AI-driven chipmakers. On July 25, Christopher Danely from Citi had also published his latest report, where he maintained a Buy rating on Analog Devices, with a price target of $290. While analysts remain confident in the company, it is worth noting the positive perspective shared by Kovitz Investment Group Partners in its Q2 2025 'Kovitz Core Equity Strategy' investor letter. The firm cited several reasons for its long-term optimism on Analog Devices, including its leadership in key markets, robust 70% gross margins that help offset tariff impacts, and an irreplaceable talent pool of 11,000 experienced analog engineers. With the stock currently at an appealing valuation, Kovitz's portfolio managers believe that it offers a compelling opportunity for investors over the next five to seven years. The company is expected to report its Q3 2025 results on August 20. Analog Devices Inc. (NASDAQ:ADI) is a semiconductor company that designs, manufactures, tests, and markets a broad portfolio of solutions using high-performance analog, mixed-signal, and digital signal processing technologies. While we acknowledge the potential of ADI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and 10 Most Oversold Semiconductor Stocks So Far in 2025. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Arcos Dorados (ARCO) Stock Trades Up, Here Is Why
Arcos Dorados (ARCO) Stock Trades Up, Here Is Why

Yahoo

time24 minutes ago

  • Yahoo

Arcos Dorados (ARCO) Stock Trades Up, Here Is Why

What Happened? Shares of fast-food chain Arcos Dorados (NYSE:ARCO) jumped 7.4% in the morning session after the company reported mixed second-quarter results that saw profits beat expectations but revenue fall short. The master franchisee for McDonald's in Latin America and the Caribbean posted earnings of $0.11 per share, easily surpassing analyst estimates of $0.08. However, total revenue of $1.14 billion missed Wall Street's expectations, growing just 2.8% year-over-year. While same-store sales, which track performance at restaurants open for at least a year, grew a solid 12.1%, this represented a significant slowdown from previous periods. The company's operating margin also declined to 5.5% from 6.7% in the same quarter last year. Investors appeared to weigh the strong profit beat against the revenue miss and decelerating growth, leading to a muted reaction for the stock. Is now the time to buy Arcos Dorados? Access our full analysis report here, it's free. What Is The Market Telling Us Arcos Dorados's shares are not very volatile and have only had 7 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was about 23 hours ago when the stock gained 4.2% as investors cheered a government report showing that inflation remained steady in July. The steady inflation figures have fueled expectations that the Federal Reserve may soon consider an interest rate cut to stimulate the economy, a move that would likely benefit consumer discretionary spending, including dining out. The July Consumer Price Index (CPI) rose 2.7% from a year earlier, meeting the previous month's pace and coming in slightly below economists' expectations of a 2.8% increase. On a monthly basis, the CPI rose 0.2%, a slowdown from the 0.3% increase seen in June. While the cost of dining out continued to climb, rising 0.3% in July, this was offset by a 0.1% dip in grocery prices, contributing to the overall stable inflation picture. The market's positive reaction sent major stock indexes, including the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite, soaring. This optimism spilled over into the restaurant sector, which has been grappling with a challenging macroeconomic environment marked by high costs and concerns over consumer traffic. Arcos Dorados is up 0.7% since the beginning of the year, but at $7.56 per share, it is still trading 25.2% below its 52-week high of $10.10 from August 2024. Investors who bought $1,000 worth of Arcos Dorados's shares 5 years ago would now be looking at an investment worth $1,583. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)
Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)

Yahoo

time24 minutes ago

  • Yahoo

Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the . On August 8, Leerink Partners analyst Mike Kratky reiterated a Buy rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT), keeping the associated price target at $83. A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room. He based the optimistic rating on the stability and growth of PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) performance, stating that the company reported a 4% sales beat in Q2. This growth was attributed to strong international momentum and higher average selling prices in the US. The analyst added that the company's full-year sales guidance was raised slightly despite a softer Q3, and the gross margin guidance was improved as well. This suggests a positive outlook for the rest of the year, according to the analyst. PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is a commercial-stage surgical robotics company that develops transformative solutions for urology. The company manufactures and sells the AquaBeam Robotic System, which is an image-guided, surgical robotic system used in minimally invasive urologic surgery. While we acknowledge the potential of PRCT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store